Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

NCT05071716 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

524

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin SSD
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.